Product Information

MYFORTIC 360 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $14.6414 per EA under NDC 00078038666. Its NADAC has been published 532 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the mycophenolic acid market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MYFORTIC 360 MG TABLET

mycophenolic acid
$14.6414per EA
High Outlier

Strength

360 mg/1

NDC

00078038666

Classification

Brand

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

1/7/2026

Active Ingredients

MYCOPHENOLATE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA050791

On Market Since

2/27/2004

Pharmacological Classes

Price Statistics

The NADAC for MYFORTIC 360 MG TABLET has been published 532 times since Nov 28, 2013, and over the history we have for it it has risen 77.0%. The table below summarizes its recorded NADAC range and movement.

Current price$14.6414 per EA
All-time high$14.6414 (Jun 24, 2026)
All-time low$8.1771 (May 21, 2014)
52-week high$14.6414
52-week low$14.3543
Median price$10.0687
Average price$10.5848
Largest weekly change+16.6% (Jun 19, 2024)
Weeks tracked532
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.0%

1Y

+1.7%

3Y

+30.9%

5Y

+30.9%

All

+77.0%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MYFORTIC 360 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MYFORTIC 360 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $14.6414 per EA (NDC 00078038666), effective Jun 24, 2026.

How has the price of MYFORTIC 360 MG TABLET changed over time?

Over the history we have for it, the NADAC for MYFORTIC 360 MG TABLET has risen 77.0%. It has been tracked across 532 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MYFORTIC 360 MG TABLET?

Since Nov 28, 2013, the NADAC for MYFORTIC 360 MG TABLET has ranged from a low of $8.1771 (May 21, 2014) to a high of $14.6414 (Jun 24, 2026), with a median of $10.0687 per EA.

Are there cheaper alternatives to MYFORTIC 360 MG TABLET?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MYCOPHENOLIC ACID DR 360 MG TB, is $0.2431 per EA — about 98% below MYFORTIC 360 MG TABLET.

Who manufactures MYFORTIC 360 MG TABLET?

MYFORTIC 360 MG TABLET (NDC 00078038666) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.